🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › Utah › Salt Lake City

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Salt Lake City, UT

Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Nagre-recruitPhase 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Nagre-recruitPhase 3
  • Huntsman Cancer Institute, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2
  • University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Nagre-recruitPhase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07061951

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Nagre-recruitPhase 1
  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05091424

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Nagre-recruitPhase 1
  • University of Utah, Salt Lake City
Edad 13 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT04771572

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

Nagre-recruitPhase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT05183854

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Nagre-recruitPhase 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 3, 2025 · NCT04844528

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2
  • University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT05643742

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Salt Lake City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.